Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009;2(5):325-31.
doi: 10.1159/000232383. Epub 2009 Aug 17.

Mechanisms of weight loss after gastric bypass and gastric banding

Affiliations
Review

Mechanisms of weight loss after gastric bypass and gastric banding

Marco Bueter et al. Obes Facts. 2009.

Abstract

The obesity epidemic is a major health problem that is associated with increased morbidity and mortality. Gastrointestinal hormones have been increasingly understood to be an important element in appetite regulation. Several gastrointestinal hormones can contribute to obesity by modulating the activity of the gut-brain axis. Bariatric surgery is currently the most effective therapy for significant and sustained weight loss in morbidly obese patients. Understanding how gut hormones are altered by bariatric procedures has contributed to our understanding of the mechanisms of appetite. In this review, we address several gastrointestinal hormones that are associated with obesity and consider how their levels are altered after bariatric surgery. The review also addresses specific effects of different gut hormones on appetite, hunger, and energy balance.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Gastric banding (pouch size: 10–20 ml).
Fig. 2
Fig. 2
Roux-en-Y gastric bypass (pouch size: 10–20 ml).

Similar articles

Cited by

References

    1. Allison DB, Saunders SE. Obesity in North America. An overview. Med Clin North Am. 2000;84:305–332. v. - PubMed
    1. Hedley AA, Ogden CL, Johnson CL, Carroll MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA. 2004;291:2847–2850. - PubMed
    1. Visscher TL, Seidell JC. The public health impact of obesity. Annu Rev Public Health. 2001;22:355–375. - PubMed
    1. Kaplan LM. Pharmacological therapies for obesity. Gastroenterol Clin North Am. 2005;34:91–104. - PubMed
    1. Thearle M, Aronne LJ. Obesity and pharmacologic therapy. Endocrinol Metab Clin North Am. 2003;32:1005–1024. - PubMed

Substances